Key Takeaways
- India demand resilient, international muted: India business posted broad-based double-digit growth across Hair Care, Home Care, and Beverages, while International grew just 2.5% in INR terms as the Middle East conflict disrupted supply chains, raised costs, and dampened demand.
- Oral Care the one sore spot: The HPC portfolio grew 17%, but Oral Care lagged at ~7%, leaving management "quite unhappy" even as Dabur gained share in a slow category. A return to double-digit growth is expected in Q1.
- Inflation is back, and pricing is the answer: Crude-linked input costs have risen ~10% across much of the HPC portfolio, prompting a 4% price hike already and a second round under review. Management will protect margins even if it means sacrificing some volume share.
- Premiumisation and portfolio shifts are working: Hair oils grew 28% on a consumer shift from coconut to value-added perfumed oils; Coconut Water doubled to a ₹100 cr ARR run-rate; and the shampoo mix is deliberately moving from sachets to higher-value bottles.
- What to watch next quarter: Whether Oral Care rebounds to double digits, the pace and consumer acceptance of the second round of price increases, and how the summer season actually plays out for glucose and nectar given unseasonal rains already appearing in the North.
India Demand & Portfolio Performance
- Hair Care firing on all cylinders: Hair oils grew 28% YoY, driven by value-added perfumed oils as rising coconut prices narrowed the price gap and pulled consumers up the ladder. Volume market share rose 154 bps. Shampoos grew 20%, with a conscious strategy to shift salience from sachets to bottles (now ~22% of mix), which is more value- and profit-accretive.
- Home Care sustained momentum: The portfolio delivered strong double-digit growth, with Odonil growing 20% on the back of aerosols and gel pockets. Dabur gained ~243 bps of market share in a category growing high single digits. New initiatives like car fresheners are planned.
- Health Care split by glucose: The digestive portfolio (Hajmola, Isabgol) grew in mid-teens, and ex-glucose the health care portfolio grew ~12.5%. Glucose itself declined ~24–25% due to unseasonal March rains in core states, optically dragging down the segment. Honey grew 25%, Isabgol 53%, Honitus 36%.
- Beverages: a tale of two tiers: Premium Activ Juices grew 26% and Coconut Water grew 100% YoY, while the larger nectar portfolio was impacted by rains. Consumer preference is shifting from drinks/nectars to juices with no artificial sugar. New PET bottles and ₹50/₹100 price points are being introduced to capture this shift.
- Nielsen disconnect: Nielsen data shows FMCG growth moderating from 11% to 9%, but Dabur and competitors are posting "spectacular results." Management speculates Nielsen may be a lead indicator: inflation could suppress volumes and bring price hikes, creating a dichotomy it cannot yet resolve.
Mohit Malhotra: "But Nielsen data is the only dampener that I see, and they are showing that FMCG growth has got muted from 11% to 9%. That said, 9% is also very respectable growth out of which partial is volume and partially is pricing, but there's been a sequential decrease. I don't know if Nielsen is a lead indicator of things to come because inflation is picking up and because of inflation, volumes will get suppressed and price hikes will come in. So that's something which is a dichotomy, which I am not able to unfold."
Oral Care: The Problem Child
- Performance below expectations: Oral Care grew only 6–7% in Q4, a sharp outlier in an HPC portfolio that grew 17%. Management is "quite unhappy" and "not even at a threshold of satisfaction." The softness was partly attributed to post-GST trade stocking in the base quarter that evened out.
- Market share still gaining: Despite the disappointment, the category itself is growing at only 2.5%, so Dabur's 7% growth represents market share gains. The herbal toothpaste segment is growing at nearly twice the rate of non-herbal, a structural tailwind Dabur is positioned to capture.
- Full-year trajectory intact: For the full year, Oral Care grew 9–10% (double-digit), and management expects a return to very strong double-digit growth in Q1, led by Dabur Red, Meswak, and Dabur Herbal. The Lal Dant Manjan brand is expected to "fire" with new initiatives.
Mohit Malhotra: "So not at all. I think we're not even at a threshold of satisfaction in terms of happiness index. We are quite unhappy with this performance because entire HPC portfolio has grown by 17% with oral care being a outlier where we've seen a muted performance of around 6%, 7% growth in Oral Care."
Inflation, Pricing & Margin Strategy
- Inflation has returned: Management had budgeted for flat inflation, but the Middle East conflict has driven input costs up roughly 10% across much of the HPC portfolio. Beverages and healthcare are relatively insulated. Crude-linked raw materials account for ~25% of the raw material basket, with packaging material exposure a little higher.
- Pricing response underway: A 4% price increase has already been announced. On larger packs, price increases will be taken directly; on ₹10 and ₹20 packs, grammage will be reduced (reversing increases made during GST) to maintain consumer price points. A second round of price increases will be considered based on how the war situation evolves.
- Margin protection is non-negotiable: Management explicitly stated it will prioritize margin over media spend when inflation is high, and is willing to accept some volume share loss if competitors do not follow on pricing. The goal is to increase margins year-on-year through product mix, pricing, cost-saving initiatives, and premiumisation.
- Q1 margin visibility: For Q1, the attempt is to at least maintain margins in the India business through price increases, grammage reduction, savings initiatives, and optimisation of trade and consumer promotion spend. Margins are expected to improve sequentially from Q4, which is seasonally the lowest due to the beverage/summer quarter.
Mohit Malhotra: "we will prioritize our margin over our media spend going forward. While we are committed doing more media and doing demand, but when the inflation is very high, it's better to protect the base business."
International Business: Middle East Weighs
- Muted headline growth: International business grew just 2.5% in INR terms, dragged down by the Middle East, which accounts for 30–35% of the international portfolio. Sub-Saharan Africa grew 20%, UK/EU 10%, Hobi 16.5%, Bangladesh 22%, and Namaste US 6.2%.
- Three-pronged Middle East impact: Supply chain disruptions are forcing the opening of newer, higher-cost routes from India, Egypt, and Turkey, eroding margins. Inflation is being passed through via price increases. Demand is declining as expatriate workers leave the region. Management hopes the situation is short-lived.
- Double-digit growth still expected: For the full year, international business is expected to grow in double digits, though volume will decline and pricing will increase. Dollar appreciation versus the rupee (~6% depreciation) provides a translation gain on the top line.
Strategic Initiatives & Portfolio Shifts
- Coconut Water scaling fast: The category is growing 100% as consumers shift from carbonated beverages to non-sin drinks. Dabur delayed entry due to lack of infrastructure but now has an AFET line with surplus capacity and is augmenting further. Current ARR is ₹100 cr, with a target exit rate of ₹150–200 cr.
- Premiumisation in Hair Care: New premium post-bath application products for hair oils and hair nourishment are planned for launch in Q1 and Q2. The Gulabari brand is being extended into larger categories like body baths, democratising across channels.
- Juice portfolio repositioning: New PET bottles and ₹50/₹100 price points are being introduced to capture the consumer shift from nectars to juices. Activ, though a small part of the portfolio, is growing 26% and represents the direction of travel.
- GST rate cut tailwind: 70% of the portfolio was on a higher tax rate that got moderated. Growth in hair oils, shampoos, and oral care (all categories where GST was cut) has been "stupendous." The GST cut also narrowed the gap between unorganised and branded players.
Mohit Malhotra: "we are bursting from scenes in terms of capacity, and we are augmenting capacity as we go on. And we'll be producing this. And whatever we are producing is what we are selling."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | High single to low double-digit growth (revised from high single-digit); ~50% from volume, balance from pricing | FY27 |
| Oral Care growth | Return to very strong double-digit growth, led by Dabur Red, Meswak, Dabur Herbal | Q1 FY27 |
| HPC growth | Double-digit growth at a bare minimum; if not high teens | FY27 |
| F&B growth | Double-digit growth for the full year, based on low base and assumption season plays out | FY27 |
| Coconut Water ARR | Exit rate of ₹150–200 cr (from current ~₹100 cr) | FY27 exit |
| Margin expansion | Increase margins year-on-year; will not compromise margins; Q1 attempt to at least maintain India margins | FY27, with Q1 visibility |
| International growth | Double-digit growth (volume down, pricing up, plus rupee depreciation translation gain) | FY27 |
| Price increases | Second round of price increases to be taken after considering war situation | Conditional on Middle East conflict evolution |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Consolidated revenue growth | 7.3% YoY |
| Domestic FMCG revenue growth | 9.5% YoY, with volume growth of 6% |
| Consolidated operating profit growth | 8.2% YoY |
| Reported PAT growth | 15% YoY |
| HPC portfolio growth | 17% YoY |
| Hair Oil portfolio growth | 28% YoY, volume market share gain of 154 bps |
| Shampoo portfolio growth | 20% YoY |
| Home Care portfolio growth | 24% YoY |
| Toothpaste portfolio growth | 7.2% YoY |
| Health care portfolio growth ex-glucose | ~12.5% YoY |
| International business growth | 2.5% YoY in INR terms |
| FY27 revenue growth guidance | High single-digit to low double-digit, revised from high single-digit; 50% from volume, balance from pricing |
| Input cost inflation | ~10% across many portfolios |
| Price increases announced | 4% across different parts of the business |
| Quick commerce salience in e-commerce | 75%, up from 50% in Q3; growth rate of 50% |